Key facts
- This page summarizes Regina E. Groves's Form 4 filing for Fulgent Genetics, Inc. (FLGT).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 20 May 2024, 18:05.
Regina E. Groves - 16 May 2024 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)
- Reporting relationship
- Director
- Issuer ticker
- FLGT
- Reported as of
- 16 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 May 2024, 18:05:57 UTC
- Prior SEC filing
- 14 May 2024
- Next SEC filing
- 19 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Paul Kim as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Regina E. Groves filed Form 4 for Fulgent Genetics, Inc. (FLGT) on 20 May 2024.
Change
- Previous filing in this sequence was filed on 14 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FLGT
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +4,000
- Change %
- +100%
- Price
- $0.000000
- Shares after
- 8,000
- Date
- 16 May 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
FLGT
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +5,481
- Change %
- Price
- $0.000000
- Shares after
- 5,481
- Date
- 16 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,481
- Exercise price
- $22.50
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 16, 2024, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date.
Footnote F2
The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 16, 2024, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date.